The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Neumora Therapeutics, Inc.(NASDAQ:NMRA)


Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.
Website: https://neumoratx.com/
Founded: 2019
IPO Price: $17 (Sep 15, 2023)
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends
Neumora Therapeutics . Op Cashflow Per Share ttm
Neumora Therapeutics . Free Cashflow Per Share ttm
Neumora Therapeutics . Cash Per Share ttm
Neumora Therapeutics . (GAAP) P/E ratio ttm
Neumora Therapeutics . P/B ratio ttm
No extra charts and metrics for this ticker.